4//SEC Filing
Harris Todd 4
Accession 0000950170-24-108533
CIK 0001863127other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 6:24 PM ET
Size
9.5 KB
Accession
0000950170-24-108533
Insider Transaction Report
Form 4
Harris Todd
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-09-19$25.10/sh−27$678→ 1,496,729 total - Sale
Common Stock
2024-09-18$24.00/sh−3,500$84,000→ 1,502,427 total - Sale
Common Stock
2024-09-19$24.30/sh−5,671$137,813→ 1,496,756 total - Sale
Common Stock
2024-09-20$24.19/sh−7,109$171,950→ 1,489,620 total
Footnotes (3)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022.
- [F2]Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $24.00 to $24.9749. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.00 to $24.8963. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Documents
Issuer
Tyra Biosciences, Inc.
CIK 0001863127
Entity typeother
Related Parties
1- filerCIK 0001711463
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 6:24 PM ET
- Size
- 9.5 KB